| Hans-Günter Meyer-Thompson | Fachartikel
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown. Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.
De Luca I, Di Carlo F, Burkauskas J, Dores AR, Carvalho IP, Gómez-Martínez MÁ, Szabo A, Fujiwara H, Barbosa CM, Di Nicola M, Mazza M, Sani G, Luciani D, Pettorruso M, di Giannantonio M, Cataldo I, Esposito G, Martinotti G, Zandonai T, Rabin O, Corazza O.
Front Public Health. 2024 Jun 19;12:1386721. doi: 10.3389/fpubh.2024.1386721. PMID: 38962770; PMCID: PMC11221326.